Xeris is a biopharmaceutical company in Chicago that sells medicines for rare endocrine and neurological diseases. It last closed at $16.97 on Nov 20, up 2.11% on the day. The next earnings report for XERS is expected around Mon, Mar 1, 2027. For the quarter ended Sep 2026, XERS reported EPS of $0.06 on revenue of $107.2M, with revenue up 44.2% from a year ago. Over its last 8 reports the stock moved an average of 13.8% the session after earnings. Over the last 12 months XERS insiders bought $0 of stock on the open market and sold $5.8M, according to SEC Form 4 filings.
AI Auto Pilots
Is XERS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold XERS.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on XERSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
XERS · as of the Nov 20 close · updated each morning
Uptrend, overbought
The stock is 18% above its 20 day and 33% above its 50 day average. It is 52% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 82), overbought. The nearest support is the Pivot at $16.84, and the nearest resistance the Pivot R1 at $17.16.
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityHigh, 4.1%/day
Key levels
$17.2852 week high+1.8%
$17.16Pivot R1+1.1%
$16.97Last close
$16.84Pivot−0.8%
$16.65Pivot S1−1.9%
$13.8820 day average−18.2%
$11.2950 day average−33.5%
$10.08Swing low (Nov 2)−40.6%
$9.84100 day average−42.0%
$8.07200 day average−52.4%
$5.2552 week low−69.1%
Indicators
RSI (14)
81.67
Overbought above 70
Overbought
MACD
1.82
Above its signal line
Bullish
Stochastic
94.2
Near the top of its range
Overbought
ADX (14)
53.0
Strong uptrend
Williams %R
-4.3
Oversold below −80, overbought above −20
Overbought
CCI (20)
73.3
Oversold below −100, overbought above 100
Neutral
Rate of change
+11.6%
Change over 10 sessions
Bullish
ATR (14)
$0.69
Typical daily range, 4.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityNormal, 7.4%/day
Key levels
$17.2852 week high+1.8%
$17.16Pivot R1+1.1%
$16.97Last close
$16.84Pivot−0.8%
$16.65Pivot S1−1.9%
$13.8820 day average−18.2%
$11.2950 day average−33.5%
$10.08Swing low (Nov 2)−40.6%
$9.84100 day average−42.0%
$8.07200 day average−52.4%
$5.2552 week low−69.1%
Indicators
RSI (14)
86.35
Overbought above 70
Overbought
MACD
2.01
Above its signal line
Bullish
Stochastic
98.2
Near the top of its range
Overbought
ADX (14)
38.2
Trending up
Williams %R
-3.1
Oversold below −80, overbought above −20
Overbought
CCI (20)
249.2
Oversold below −100, overbought above 100
Overbought
Rate of change
+127.8%
Change over 10 sessions
Bullish
ATR (14)
$1.26
Typical daily range, 7.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for XERS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how XERS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow XERS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for XERSHow many large options trades hit XERS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in XERS in the last 90 days.
From SEC Form 4 filings by XERS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XERS is in one of them and how their past XERS trades turned out.
Xeris is a biopharmaceutical company based in Chicago, Illinois, that develops and sells medicines for chronic endocrine and neurological diseases in the United States. Its marketed products include Recorlev for Cushing's syndrome, Gvoke, a glucagon treatment for severe low blood sugar, and Keveyis for primary periodic paralysis. Its customers include patients and the clinicians who treat them, and it is developing a weekly injectable form of levothyroxine for hypothyroidism.